← Back to directory

James S. O’Donnell

Researcher Next ID · RN-040676

Researcher · Immunology and Microbiology

Royal College of Surgeons in Ireland

Dublin, Ireland

Accepting doctoral researchersFunding unknown
Works count
330
Citation count
12,493
H-index
53
i10-index
167

Research interests

Immunology and Microbiology
Medicine
Platelet Disorders and Treatments
Blood Coagulation and Thrombosis Mechanisms
Hemophilia Treatment and Research
Blood groups and transfusion
Complement system in diseases

Publications

  • ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

    Blood Advances · 2021 · 10.1182/bloodadvances.2020003265

  • Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response

    Journal of Thrombosis and Haemostasis · 2021 · https://doi.org/10.1111/jth.15267

  • Persistent endotheliopathy in the pathogenesis of long COVID syndrome

    Journal of Thrombosis and Haemostasis · 2021 · 10.1111/jth.15490

  • The relationship between ABO blood group, von Willebrand factor, and primary hemostasis

    Blood · 2020 · 10.1182/blood.2020005843

  • Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia

    The Lancet Rheumatology · 2020 · 10.1016/s2665-9913(20)30121-1

  • COVID19 coagulopathy in Caucasian patients

    British Journal of Haematology · 2020 · 10.1111/bjh.16749

  • Endothelial cells orchestrate COVID-19 coagulopathy

    The Lancet Haematology · 2020 · 10.1016/s2352-3026(20)30215-5

  • Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels

    Blood · 2017 · 10.1182/blood-2017-05-786699

  • The diagnosis and management of von W illebrand disease: a U nited K ingdom H aemophilia C entre D octors O rganization guideline approved by the B ritish C ommittee for S tandards in H aematology

    British Journal of Haematology · 2014 · 10.1111/bjh.13064

  • Elevated factor VIII levels and risk of venous thrombosis

    British Journal of Haematology · 2012 · https://doi.org/10.1111/j.1365-2141.2012.09134.x

  • Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance

    Haemophilia · 2009 · 10.1111/j.1365-2516.2009.02005.x

  • Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings

    Blood · 2009 · 10.1182/blood-2009-07-235150

  • Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation

    Blood · 2009 · 10.1182/blood-2009-05-222109

  • von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation

    British Journal of Haematology · 2006 · 10.1111/j.1365-2141.2006.06067.x

  • ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?

    Transfusion · 2006 · 10.1111/j.1537-2995.2006.00975.x

  • Proteolytic inactivation of ADAMTS13 by thrombin and plasmin

    Blood · 2004 · 10.1182/blood-2004-03-1101

  • Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage

    Neurology · 2004 · 10.1212/01.wnl.0000138428.40673.83

  • Amount of H Antigen Expressed on Circulating von Willebrand Factor Is Modified by ABO Blood Group Genotype and Is a Major Determinant of Plasma von Willebrand Factor Antigen Levels

    Arteriosclerosis Thrombosis and Vascular Biology · 2002 · 10.1161/hq0202.103997

  • The relationship between ABO histo‐blood group, factor VIII and von Willebrand factor

    Transfusion Medicine · 2001 · 10.1046/j.1365-3148.2001.00315.x

  • Bleeding symptoms and coagulation abnormalities in 337 patients with AL‐amyloidosis

    British Journal of Haematology · 2000 · 10.1046/j.1365-2141.2000.02183.x

  • High Prevalence of Elevated Factor VIII Levels in Patients Referred for Thrombophilia Screening: Role of Increased Synthesis and Relationship to the Acute Phase Reaction

    Thrombosis and Haemostasis · 1997 · 10.1055/s-0038-1656061

Current projects

    No projects listed.